Hims & Hers rockets higher after Novo Nordisk to distribute weight-loss drugs on its platform
Hims & Hers Health stock jumped about 40% after Novo Nordisk announced it would distribute weight-loss medications on the Hims & Hers platform, signaling a potential major partnership and upside for the telehealth company.